In a follow-up study of >8000 nonmetastatic breast cancer cases, we demonstrated that the ICR signature was the strongest independent prognostic predictor for metastatic relapse, in particular for patients with Her2+-enriched and triple-negative breast tumors54. The gene discussed is ERBB2; the disease is breast cancer.